Article
A protein interaction map identifies existing drugs targeting SARS-CoV-2
2020-06-10
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Severe acute respiratory syndrome coronavirus (SARS-CoV-2), an emerging Betacoronavirus, is the causative agent of COVID-19. Angiotensin converting enzyme 2 (ACE2), being the main cell receptor of SARS-CoV-2, plays a role in the entry of the virus into the cell. Currently, there are no specific antiviral drugs for the treatment and neither preventive drugs such...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a80a82e5-7596-5a7b-90d3-429c4c477945
- DOI
- 10.21203/rs.3.rs-33987/v1
